An observational study in Obsessive-Compulsive Disorder, sponsored by NOCD. Completed at 1 site in United States. Open to participants aged 10 Years and older. Per ClinicalTrials.gov, last updated 2021-01-08.
Sponsored by NOCD · Observational
This is a naturalistic, observational study of individuals with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy, augmented with between-session support with text messaging and an online community forum.
367 studies on the registry are indexed under Compulsive Personality Disorder; 67 are open to participants now.
This study's enrollment of 2,069 is above the median of 102 across 41 observational studies indexed under Compulsive Personality Disorder.
Browse Compulsive Personality Disorder studies →NOCD is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
This is a naturalistic sample of children, adolescents, and adults with obsessive-compulsive disorder (OCD) who sought treatment for OCD from NOCD, LLC, a digital behavioral health company.
Exclusion Criteria:
adults, adolescents, and children with obsessive-compulsive disorder
Behavioral: Exposure and response prevention therapy
Exposures and response prevention therapy (a type of cognitive-behavioral therapy for obsessive-compulsive disorder), delivered in real-time by licensed therapists remotely via video. The treatment was augmented by between-session text messaging and online community support.
Dimensional Obsessive-Compulsive Scale
self-rated psychometric instrument to measure symptom severity of multiple OCD subtypes
Time frame: change from pre-treatment to post-treatment (after 11 weeks)
Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND) OCD severity scale
clinician-rated psychometric instrument to measure overall OCD symptom severity
Time frame: pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)
Depression Anxiety and Stress Scale (DASS-21)
self-rated psychometric instrument to measure depression, anxiety, and stress
Time frame: pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)
Quality of Life Enjoyment and Satisfaction Questionnaire -- Short Form (QLES-Q)
self-rated psychometric instrument to measure quality of life
Time frame: pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)
This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Compulsive Personality Disorder→
NOCD